In LPS-induced neuroinflammation models, ALC confers neuroprotection by suppressing the TLR4/NFB pathway, restoring autophagy activity, and inhibiting oxidative stress.[13] ALC reduces microglial activation and release of inflammatory mediators by balancing pro-inflammatory and anti-inflammatory cytokines.[14][15] ALC attenuates microglial activation in a dose-dependent manner, with 100 mg/kg/day showing beneficial effects on LPS-induced neuroinflammation in mice, associated with increased brain-derived neurotrophic factor (BDNF) concentration.[14] In repetitive mild traumatic brain injury models, ALC treatment showed protective effects against neurodegeneration and inflammation, reducing mRNA levels of MAPT, TNF, and GFAP in the cortex.[16] Combination Strategies for Neuroinflammation: ALC 1,500-2,000 mg/day + PEA 1,200 mg/day (complementary anti-inflammatory mechanisms) + Omega-3 fatty acids 2-4 g/day (specialized pro-resolving mediator precursors) + Curcumin 500-1,000 mg/day (complementary NF-B modulation) 4

(8) As both TB-500 and BPC-157 peptides appear to exhibit similar pharmacological potential, when blended together, the potential action of both may be maximized what would otherwise occur with one peptide, might occur at a better, faster rate when combined
Beard JR, Officer A, Carvalho IA, Sadana R, Pot AM, Michel JP, Lloyd-Sherlock P, Epping-Jordan JE, Peeters GM, Mahanani WR, Thiyagarajan JA, Chatterij S (2016) The world report on ageing and health: a policy framework for healthy ageing
Please call our office today to schedule a consultation with certified Nurse Practitioner Brittany Wilson or one of our highly skilled specialists.